Here’s whether Edwards Lifesciences Corp (EW) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+1.27% over 10 days); RSI 48 — healthy momentum range; strong 1-year return of +12.2%. Currently 4.9% off its 52-week high. Score: +6/7.
EW is in a confirmed uptrend, trading above both its 50-day ($82.78) and 200-day ($81.84) moving averages. An RSI of 47.8 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +12.2% compares to +22.9% for SPY (trailed the market by 10.7%).
$10,000 invested 1 year ago→ $11,215 today
vs. S&P 500 (SPY) — same period trailed market by 10.7%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($81.84)
✓Above 50-day MA ($82.78)
✓RSI(14) neutral zone (30–70) — currently 47.8
✓Positive return (+12.2%)
✓Within 10% of period high (−4.9%)
Period Range $85.11
$72.30$89.48
RSI (14) 47.8
0 · OversoldOverbought · 100
Key Metrics
Price$85.11
Period Return+12.2%
Period High$89.48
Period Low$72.30
Drawdown−4.9%
MA-50$82.78
MA-200$81.84
RSI (14)47.8
Avg Volume (30d)4.9M
vs. SPYtrailed by 10.7%
Return Rank#587 of 1246
Trend Signals
Price is above the 200-day moving average ($81.84)